User profiles for "author:G Parmigiani"
Giovanni ParmigianiProfessor Department of Data Science, DFCI Verified email at dfci.harvard.edu Cited by 62609 |
The analysis of gene expression data: an overview of methods and software
This chapter is a rough map of the book. It provides a concise overview of data-analytic tasks
associated with microarray studies, pointers to chapters that can help perform these tasks …
associated with microarray studies, pointers to chapters that can help perform these tasks …
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts
PURPOSE: Published reports suggest that DNA microarrays identify clinically meaningful
subtypes of lung adenocarcinomas not recognizable by other routine tests. This report is an …
subtypes of lung adenocarcinomas not recognizable by other routine tests. This report is an …
An integrated genomic analysis of human glioblastoma multiforme
…, DD Bigner, R Karchin, N Papadopoulos, G Parmigiani… - science, 2008 - science.org
Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer. To
identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes …
identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes …
The genomic landscapes of human breast and colorectal cancers
…, P Buckhaults, SD Markowitz, G Parmigiani… - Science, 2007 - science.org
Human cancer is caused by the accumulation of mutations in oncogenes and tumor
suppressor genes. To catalog the genetic changes that occur during tumorigenesis, we …
suppressor genes. To catalog the genetic changes that occur during tumorigenesis, we …
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
…, R Karchin, N Papadopoulos, G Parmigiani… - science, 2008 - science.org
There are currently few therapeutic options for patients with pancreatic cancer, and new
insights into the pathogenesis of this lethal disease are urgently needed. Toward this end …
insights into the pathogenesis of this lethal disease are urgently needed. Toward this end …
The consensus coding sequences of human breast and colorectal cancers
…, AF Gazdar, J Hartigan, L Wu, C Liu, G Parmigiani… - science, 2006 - science.org
The elucidation of the human genome sequence has made it possible to identify genetic
alterations in cancers in unprecedented detail. To begin a systematic analysis of such …
alterations in cancers in unprecedented detail. To begin a systematic analysis of such …
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of …
…, S Mirrett, LG Reimer, G Parmigiani… - Clinical Infectious …, 1997 - academic.oup.com
To assess changes since the mid-1970s, we reviewed 843 episodes of positive blood
cultures in 707 patients with septicemia. The five most common pathogens were …
cultures in 707 patients with septicemia. The five most common pathogens were …
[HTML][HTML] Meta-analysis of BRCA1 and BRCA2 penetrance
S Chen, G Parmigiani - Journal of clinical oncology: official journal …, 2007 - ncbi.nlm.nih.gov
Purpose Genetic counseling is now routinely offered to individuals at high risk of carrying a
BRCA1 or BRCA2 mutation. Risk prediction provided by the counselor requires reliable …
BRCA1 or BRCA2 mutation. Risk prediction provided by the counselor requires reliable …
The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions
…, EMH Kim, F Polubriaginof, G Parmigiani… - Breast cancer research …, 2012 - Springer
Women with atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular
carcinoma in situ (LCIS), and severe ADH are at increased risk of breast cancer, but a …
carcinoma in situ (LCIS), and severe ADH are at increased risk of breast cancer, but a …
[HTML][HTML] Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
…, M Fulciniti, PG Richardson, G Parmigiani… - Nature …, 2014 - nature.com
Multiple myeloma is an incurable plasma cell malignancy with a complex and incompletely
understood molecular pathogenesis. Here we use whole-exome sequencing, copy-number …
understood molecular pathogenesis. Here we use whole-exome sequencing, copy-number …